Sponsored by

VGoodiez 420EDC
  • Welcome to VaporAsylum! Please take a moment to read our RULES and introduce yourself here.
  • Need help navigating the forum? Find out how to use our features here.
  • Did you know we have lots of smilies for you to use?

Law Maryland MMJ


Ah, that Mom is on the ball. Good thing we pay her a lot.....or do we? hahaha

So, MD's program was to have reciprocity but they haven't implemented it yet and they are dithering about over something


From MMCC website
Any person who lives in Maryland can participate in the program.

A person from out-of-state who is in the state for the purpose of receiving medical care can be issued a written certification and obtain medical cannabis.

Important: Effective December 14, 2017 the Commission extended the administrative hold on out-of-state patient applicants until further notice. As a result of this hold, out-of-state patient applications will not be reviewed at this time, and applicants who live outside the State may not access medical cannabis at Maryland licensed dispensaries. Please see Bulletin: 2018- 002 for additional information.
-----------------------

Commission Extends Administrative Hold on Out-of-State Patient Applicants
Bulletin: 2018- 002
Effective Date: February 16, 2018

Linthicum, MD (February 16, 2018) - On October 23, 2017, the Maryland Medical Cannabis Commission ("'Commission'') placed a 60-day administrative hold on all out-of-state patient applications. Effective December 14, 2017, the Commission extended the administrative hold on out-of-state patient applicants until further notice. As a result of this hold, out-of-state patient applications will not be reviewed at this time, and applicants who live outside the State may not access medical cannabis at Maryland licensed dispensaries.

The Commission continues to evaluate potential regulatory changes to the medical cannabis regulations, including the definition of "qualifying patient," and public comment received in response to these potential changes. The administrative hold on out-of-state patient applicants will continue until the Commission addresses any regulatory changes that may be needed to carry out the statutory language enacted in three Acts by the General Assembly between 2013 and 2015.

Please visit the Commission's website at mmcc.maryland.gov for additional information. For patient inquiries, please contact mdh.infoandregistration@maryland.gov or 1-844-421-2571.​

This bulletin does not change, remove, or replace any existing regulations under COMAR 10.62
----------------------------------------
From MD MMJ FAQ
However, if you get a med card from VA, then DC has now opened reciprocity and they will honor your card...this started in late April '18

Hope this is helpful to you .
 
Interesting. So in the future if they lift the admin hold on out of state patient registrations, a VA resident whom is seeking medical attention in MD can apply for MMJ.

The state of VA does not have an MMJ program so there are no cards. I can get an affidavit that permits me to use oils that contain 5% THC or less but thats not really helpful considering I need high THC doses. Also the affidavit program offers no sources so I would still be left to an unregulated black market.

I really just want regulated meds.
 
So in the future if they lift the admin hold on out of state patient registrations, a VA resident whom is seeking medical attention in MD can apply for MMJ.

Kind of hard to say what the rules for out of state patients getting a MD MJ card or for reciprocity of other states cards since its not finalized in any way yet.

It was that any out of state citizen who was in MD could apply for a card. Now the language....still not final or in effect....morphed into that you need to be in MD to receive medical treatment (like say you were part of a study at NIH) and under those circumstances MD would issue you a card.

But again, no final wording and nothing actually in effect. Also, no deadline for it to be put into effect if ever.
 
I'm just starting to see more brands for sale, more strain variety, and an improvement in quality as well as some deals popping up. Concentrates are still way too damn expensive and the article below addresses the status of growers and dispensaries but where the hell are the rest of the processors?? We have fourteen of them licensed but I'm not seeing 14 different brands (but have seen a couple of new brands pop up recently).

Now, this article...as does just about every other one about the MD MMJ program, addresses diversity extensively. Not for this thread, or even this board, but personally I don't find anything intrinsically beneficial to "diversity" Equal opportunity...I'm ALL about it. But we seem to have accepted that there is some innate goodness in diversity without question. Well, I question it. And what does diversity mean? Do we have to make allowances and ensure we have people both shorter and taller than the morm? How about thin and fat. Certainly we need every type of hair color. How about nationalities? I'm sure Hmong people would love to have some sort of set aside or preferential treatment to ensure that they are represented in every possible group.

Ok, leaving this topic now. LOL



6 Months On, Maryland Patients Struggle With Limited Selection and Supply


Maryland’s cannabis industry surprised Amy Mellen when she moved here from Oregon in 2016. She had migrated from a state where 87 percent of residents are white to a state where roughly three in 10 residents are black.

But when Maryland state regulators announced their preliminary picks that year for medical marijuana licenses—15 apiece for growers and processors—not a single grower and only one processing company was black-owned. The lack of consideration for diversity as a factor shocked her, she says.

Maryland is still struggling to manufacture concentrates, and the state has banned edibles. What’s more: the supply chain is still almost entirely white-owned.
“You have so many different nationalities here, and so many different people in this melting pot,” says Mellen, recently hired as a patient counselor at a dispensary in Upper Marlboro, about 20 miles southeast of Washington D.C. “Why would they not consider it?”

Maryland’s first medical marijuana dispensaries opened in December 2017, with just 10 of 102 planned retailers licensed. As of late May, about a half-year in, nearly four dozen were up and running, Maryland Medical Cannabis Commission (MMCC) chairman Brian Lopez told Leafly.

Flower prices and availability—once expensive and lacking, respectively, when sales kicked off—have gradually improved as growers and processors have begun to fill store shelves to meet patient demand. But Maryland’s industry is still struggling to provide adequate and affordable options for concentrates, and has barred dispensaries from selling edibles. And what’s more: the supply chain is still almost entirely white-owned.

‘Actively Seek Diversity’
The 2014 law that created the state’s cannabis legal framework directed the MMCC to “actively seek to achieve racial, ethnic, and geographic diversity” among licensees. But regulators opted not to prioritize race in the selection process. They cited a letter from the state attorney general’s office that advised doing so could be unconstitutional without an existing history of racial disparity in the industry.

The state’s Legislative Black Caucus has since pushed to add more licenses for minority entrepreneurs, and require the commission to factor race into the application process. Gov. Larry Hogan, a Republican, ordered a disparity study on the matter. That study concluded the state could do more to “remediate discrimination” against minorities and women “in the types of industries relevant to the medical cannabis business.”

This year, caucus chairwoman Del. Cheryl Glenn (D-Baltimore) introduced a bill to mandate that the commission consider race in cannabis license applications. Glenn’s bill would also add seven growing and 13 processing licenses, better address “needs” and barriers for minorities and female entrepreneurs, and create a “compassionate use fund” to assist low-income and veteran patients obtain their medicine.

The General Assembly passed the measure, and Hogan signed it into law on May 15.

Who Got the Licenses
In a recent interview with Leafly, Glenn confirmed that some of the additional licenses are already taken. Seven Points Agro-Therapeutics, the state’s sole black-owned processor, has been promised a grower’s license. Several existing growers have also been guaranteed processor licenses. Two companies that sued the commission over its selection process in 2016 were promised licenses as well.

But more than a dozen are still up for grabs, Glenn notes. She remains bullish that her legislation will help solve the diversity problem: “It’s absolutely going to be helpful.”

Still, the new a diversity mandate doesn’t necessarily eliminate economic barriers to minority involvement. One big issue, Lopez acknowledges, is financing.

“It’s very expensive,” the MMCC chairman says, “and you have to have a high qualification to get into the business.”



$5 to $10 Million to Start
Ted Rubholz is the president of Temescal Wellness, a Baltimore-based grower, processor and dispensary. He says a dispensary alone can require at least $250,000 in startup capital.

The price tag increases from there, Rubholz adds. “As you go up the supply chain—especially when you talk about cultivation—if you’re going to achieve a capacity out of the gate that’s where you can actually be a consistent supplier, you’re probably looking at at least $5 million. Most folks budget at least $10 million.”

Hidden Barriers
Statistically speaking, white people are financially better off than people of color in Maryland. The median incomes for black and Hispanic households in Maryland from 2011 to 2015 were $59,021 and $62,463, respectively, according to U.S. Census data. For white households, it was $83,055.

In Maryland, nearly 14 percent of blacks and 12.4 percent of Hispanics lived at or below the poverty line in 2016, compared to 7.6 percent of whites, per an analysis of Census data by the Center for American Progress, a liberal think tank.

One way of “ensuring that a wide diversity of people can enter this marketplace as entrepreneurs,” Rubholz suggests, is for states to “eliminate any requirements for vertical integration”—that is, licensing the same company to grow, process and dispense cannabis, as his company does—“to maximize the accessibility for all types of folks” to open businesses.

More Products, Lower Prices Expected
Beyond improving diversity, patients and advocates hope the addition of grower and processor licenses will beef up Maryland’s cannabis supply chain, lowering prices and meeting patient demand.

Flower prices have improved since the state’s first dispensaries opened in December 2017, but concentrates and topicals are still in short supply and can be prohibitively expensive, patient advocates say.

'When you only have a certain number of growers, you’re only gonna get certain strains that come along.'
Amy Mellen, medical cannabis patient counselor
“Dispensaries will get 20 grams of oil in a shipment, and they won’t get any more for weeks at a time,” says Max Davidson, executive director of the Maryland Patient Rights Association and an assistant general manager for a dispensary in Baltimore County.

A gram of concentrate generally costs about $100, he says, and a cartridge of oil generally goes for $70 to $90, depending on geography. The comparative black market rate ranges from $25 to $50, he says.

And inventory doesn’t last long. “A strain will appear and then disappear, and then it’s gone,” Davidson says. “You won’t see it again for sometimes weeks or months.”

Few Growers Out There
Mellen has heard similar complaints from patients. The state’s limited pool of growers also limits the selection of strains.

“When you only have a certain number of growers and you’re going through harvest cycles, you’re only gonna get certain strains that come along,” she says.

When the industry came online in December 2017, Lopez notes, only one or two growers had harvests ready to deliver, and just two of the state’s 10 licensed dispensaries actually opened.

Fortunately, that situation has improved. “All of our growers are now producing,” he says. Forty-six dispensaries have opened as of mid-May. Lopez expects 90 percent of the state’s 102 approved dispensaries will be licensed by the end of the year.

He also expects prices to fall as more competition and ramped-up production work their way into the market.

As for product availability, Lopez suggests patients can control what processors are putting out by giving feedback to their dispensaries, which will then pass word on to suppliers. It’s basic economics, he says. “If the demand is there and people are requesting it, it’s going to come out.”

Patient Worries: Guns, Drug Tests
Patients have other concerns as well. Both Davidson and Joie Leigh, director of public outreach for the Maryland chapter of the National Organization for the Reform of Marijuana Laws (NORML), say patients fear Maryland state officials will prohibit them from buying or owning guns because they’re registered with the commission. Some worry their employers could fire them for testing positive for THC during drug tests.

Mellen also says patients have complained that the state’s Metrc system, which tracks cannabis supply, has double-counted their flower into their monthly limits by also calculating the concentration of THC in their purchases and applying it toward their maximum for concentrates.

MCCC chairman Lopez says he hasn’t “heard a lot of issues” about Metrc, but says it “does have a formula that it comes up with in order to identify what the maximum is.” He recommends patients call their provider or the MMCC to learn more.


RELATED STORY
Can Medical Marijuana Patients Legally Own Guns?

Wait, No Edibles?
Edibles are a big issue. MMCC regulations don’t allow retailers to sell them. Mellen says the state “has really kind of shot themselves in the foot” in this way, pointing to the loss of potential tax revenue.

State regulators banned edibles due to concerns about accidental ingestion by children and worries about the FDA.
Asked why edibles aren’t permitted, Lopez cites concerns about accidental ingestion by children and a desire to keep the U.S. Food and Drug Administration (FDA) from intervening to regulate food products, such as baked goods.

Although Lopez cites the FDA, in fact no medical or adult-use state that allows edibles has run into trouble with the federal agency. As John Mansfield, a leading cannabis lawyer with the Portland, Oregon, firm Harris Bricken, has noted, “the FDA’s role in food is essentially hands-off. Though the FDA has promulgated hundreds of pages of food regulations, it mostly relies on food makers to self-enforce these regulations.”

The FDA has sent warning letters to CBD makers who make claims about the substance healing cancer, multiple sclerosis, diabetes, and a host of other conditions. But it has not interfered with cannabis-infused edibles, including baked goods, in states that allow the sale of such products.

Patients Want More Choices
The MMCC chairman notes that patients have expressed interest in orally ingestible elixirs and tinctures. The commission is planning to accept public feedback and “work with the stakeholders and the industry on how to resolve it,” he says.

Glenn supports the change, and says she will consider proposing legislation in 2019 to make edibles available at dispensaries, assuming she gets re-elected to her seat in November.

“You can’t do it all at the same time,” she says. “You have to be very diligent in prioritizing those factors and those issues that are most important for the industry.”

Mellen was impressed with the initial rollout of medical cannabis in Maryland, particularly the speed at which patients could obtain medical cards and the fact that product labels contained specific terpene profiles. Still, she argues the state owes patients more attention to their concerns.

“This program was created for the people of Maryland, it was voted for by the people of Maryland,” she says. “This is a program the state is to provide for the people of Maryland.”
 
Prices are coming down but still high. Variety is still limited but growing. All in all, MD's program is easy to navigate, has very good 30 day buy limits, and everything is tested and regulated which relieves a lot of people's concerns.


The Maryland cannabis market matters more than companies may realize


The grass is getting much greener for the cannabis industry on the East Coast, as Maryland continues to ramp up the licensing of dispensaries.

Though the Maryland Medical Cannabis Commission approved 102 dispensaries initially, only 50 of have been fully awarded. Despite the slow rollout, that hasn’t stopped cannabis companies like Leaflink and Green Bits from arriving on the scene.


The company has four cannabis brands live on the platform now for Maryland. According to Smith, the platform lets retailers stay compliant with brands they’re purchasing from by making sure licenses are in good standing in each state.

While entering the Maryland market definitely helps Leaflink grow, there are several other reasons for entering, such as opening up where brands on the platform are going.

“In some of these East Coast states, we’ve seen a lot of capital being raised and companies launching with the brand in mind from the very beginning,” Smith said. “And I think we’ll keep seeing more of that as more states come online, because most companies are thinking about not just the state they’re in, but the next one they want to grow into.”

Ben Curren, co-founder and CEO at Green Bits, a cannabis retail platform that also operates in Maryland, recommends that cannabis companies get into the market now, before it’s too big but also because the state represents how the weed market can operate there.

“As Massachusetts comes online, people will look to Maryland,” Curren said. “It’s a better market where it’s controlled and people are getting their medicine.”

It also helps that Maryland is in Congress’ backyard, which enables more representatives to see the cannabis market evolve and to form their own opinions, Curren said.

Maryland isn’t the only East Coast state that should be on your cannabis radar: Legalization for either medical or recreational use is set to hit New Jersey, Massachusetts and Pennsylvania, with Massachusetts expected to come online on July 1.

“Maryland was important for us because it was the first East Coast state,” Smith said. “It’s the first of many now to go if not medical, [at least] recreational.”
 
All of this may be so, but Hogan has a 70% approval rating in my very blue state of MD because he governs from the middle and he has been able to do this effectively with a completely Dem state Senate and House. Personally, I like Hogan and believe that he represents a very viable alternative to the very polarizing candidates put up lately in our country by both parties.


Voters In Two States Nominate Marijuana Legalization Supporters for Governor


Tuesday’s primary elections brought in a wave of Democratic gubernatorial candidates who’ve endorsed marijuana legalization—from Maryland to Colorado.

Here’s a breakdown of where the gubernatorial primary winners stand on cannabis.

Maryland
Democratic winner: Ben Jealous, former NAACP president

Jealous campaigned as a progressive, pro-legalization candidate for governor, earning him the endorsements of Sen. Bernie Sanders (I-VT) and Kamala Harris (D-CA), among others. He spoke to Marijuana Moment earlier this month about how comedian Dave Chappelle first put the idea of legalization in his head—and how his stance on cannabis reform further evolved after studying racial disparities in marijuana enforcement as well as the economic potential of full legalization. Jealous told Marijuana Moment that, if elected governor, he would use tax revenue from a legal cannabis retail system to fund universal pre-k education throughout Maryland.
upload_2018-6-28_13-44-43.png

“We know that we have to end mass incarceration—and yet go further,” he said. “We have to really get back to opening up the gates of opportunity for all of our children. And by legalizing cannabis, we get to make progress on both fronts.”

Every single Democratic gubernatorial candidate in Maryland backed legalization during the primary, The Baltimore Sun reported, but Jealous seemed to focus on it more than most other major contenders.

Republican winner: Larry Hogan, incumbent governor

Hogan hasn’t taken an official stance on full marijuana legalization and, notably, declined to respond to a question about whether he felt voters should be entrusted to make that decision as part of a state referendum last year.

Just ahead of the primary election this week, however, Hogan said that “[a]t this point, I think it’s worth taking a look at” in reference to full legalization.

“I was for medical cannabis. I want to make sure we’re off to the right start and we look at every aspect of the issue.”

The governor signed a bill last month that expanded Maryland’s medical marijuana program. The legislation called for increased licenses for cannabis processors and growers; it was also designed to resolve the lack of diversity among individuals and businesses that receive these licenses.
 
Maryland's medical cannabis commission approves another 7 dispensaries

The Maryland Medical Cannabis Commission expects to have licensed about 70 dispensaries by the end of next month, with hopes to clear the more than 100 pre-approved marijuana retailers for openings by 2019.

The regulatory body for Maryland's medical marijuana industry awarded preliminary licenses to 102 separate dispensaries in November 2016. Initially, the commission expected the final licensing process to take only a year. Seventeen months later, the body continues to approve only a handful of ready businesses at a time. But the industry is inching ever closer to full initial capacity.

In June, the commission offered final approval to another seven dispensaries throughout the state, including three in Greater Baltimore. Jennifer White, a spokeswoman for the commission, said another 12 or 14 dispensaries are expected to gain final licensure next month. Another 30 or so will remain after that.

If the commission keeps up its current pace — issuing about six licenses on average per month — all the pre-approved dispensaries should be ready to serve the growing cannabis patient population by the end of the year.

The demand for medical cannabis products in Maryland continues to grow. Since December, about 29,000 people have been added to the pool of registered cannabis patients. Of the 47,086 registered thus far, 2,702 are caregivers who may purchase cannabis on behalf of someone else, 172 are minors and 169 are hospice patients. There are 946 registered providers, or those who can prescribe cannabis, in Maryland.

Here's where the newly licensed businesses can be found:

  • True Wellness Aberdeen at 226 S. Philadelphia Ave., Aberdeen
  • Health For Life Bethesda at 4909 Fairmont Ave., Bethesda
  • Chesacanna Inc. at 10534 York Road, Cockeysville
  • GreenLabs Inc. at 1522 Eastern Ave., Baltimore
  • StoreHouse at 5730 Falls Road, Baltimore
  • Zenity Wellness at 8355 Snouffer School Road, Gaithersburg
  • Elevate Takoma at 3609A New Hampshire Ave., Takoma Park
The BBJ has been tracking the growth of the medical cannabis industry through our interactive map. Scroll around to see how many dispensaries have opened near you.

Maryland is set to have more than 150 cannabis businesses in total operating statewide. In addition to dispensaries, the cannabis commission initially pre-approved 15 growers and 15 processors to launch operations in the state. And per a piece of legislation passed in the 2018 General Assembly, 20 additional growing and processing businesses will be able to join the market over the coming year. Fourteen growers and 15 processors have gained their final operating licenses thus far — many of them have opted not to share their addresses publicly and cannot be included on the BBJ's map.
http://www.baltimoresun.com/news/maryland/politics/bs-md-cannabis-pesticides-20180705-story.html

The article below is somewhat distressing. ForwardGro is one of the large cultivators here in MD and was one of two who had product available at the start of the program. I have met some of their folks and they look as honest and as responsible as you would expect...but who knows. If this is true, they are going to have their pee-pee well and truly whacked for it. But the most distressing part is MD allowing "minimum risk" pesticides going forward. Minimum risk to who...the grower's financials or the med patient's health? Hmmm?

Regulators investigating Maryland medical marijuana grower for alleged pesticide use

State regulators are investigating allegations that a politically connected medical marijuana grower in Maryland illegally used pesticides in growing cannabis plants that were later harvested for sale to patients.

Three former employees at the Anne Arundel County growing center of the cannabis producer ForwardGro made the charges in sworn allegations sent to the General Assembly last week by a newly formed association of companies in the medical marijuana business that oppose pesticide use in growing the plants.

Ashley Colen, president of the Maryland Ethical Cannabis Association and the holder of a dispensary license, said she stopped selling products from ForwardGro’s plants after learning of the allegations. Colen, co-owner of the Ash+Ember dispensary in Centreville on the Eastern Shore, said some of her customers reported side effects such as burning eyes and throats.

“This is about patient safety, not about money,” she said. “We’re supposed to be looking out for the patients.”

Colen said she has discussed the allegations with Joyce Strand, executive director of the Maryland Medical Cannabis Commission.

A commission spokesman, Jennifer White, said the agency is investigating.

“Of course we take all of this information seriously, and the Bureau of Enforcement and Compliance here with the commission is looking into it,” she said.

ForwardGro issued a statement categorically denying the allegations and calling them “an attack on our business.”

“Every ForwardGro batch was properly tested by an independent testing lab and we have never had any product fail for pesticides,” the company said. “Patient advocacy and patient safety have always been, and will always be, our priority. We are following the path driven by the Maryland Medical Cannabis Commission and are cooperating fully with them.”

The company said that once the commission’s investigation is complete, it will be prepared to comment further.

ForwardGro is co-owned by Gary Mangum, a prominent supporter of Larry Hogan who served on the governor’s inaugural committee and transition team. According to the affidavits, Mangum took part in two meetings in April in which greenhouse workers informed him about their concerns about “illegal pesticide application” at the company’s growing facility.

Mangum declined to comment for this article. He referred a reporter to a company spokeswoman, who released the statement.

All three affidavits describe persistent use of pesticides in the company’s greenhouse by employees who were told not to discuss their use with ForwardGro’s compliance officer. Two of the employees, brothers Evan and Brandan Norris, said they worked there from January through April of this year.

White said that during that period, and earlier, the use of pesticides in growing medical cannabis was illegal.

The third ex-employee, Brad MacDonald, said he began work at ForwardGro in April 2017 before the first plants were delivered to the Lothian facility. McDonald described a crop that was infected with powdery mildew from the beginning and later was infested with spider mites and other pests. He said he was instructed by supervisors beginning in June 2017 to spray or douse the plants with a variety of pesticides and other chemicals.

MacDonald said that in February he was ordered by a supervisor not to talk to the compliance officer about “anything to do with the cultivation process” or issues concerning pesticides, according to his sworn affidavit. But in April, MacDonald said, he became “tired of lying” and he and Evan Norris brought their concerns to the compliance chief, whose job was to see the company followed commission rules.

The Norrises said they quit in late April. MacDonald said he stayed until June 19 and continued to spray pesticides that were given code names.




During this year’s legislative session, lawmakers adopted an amendment to a much broader medical marijuana bill opening the door to the use of pesticides. The provision instructed the Department of Agriculture to develop emergency regulations by June 1 on acceptable forms of pest control. Interim rules, which allow the use of pesticides the federal government classifies as “minimum risk,” took effect Friday after they were approved by a legislative committee that reviews proposed regulations.

It was not clear whether the pesticides named in the affidavits would have been acceptable under the interim regulations, which do not list specific products. The interim rules are in effect until September. State officials are expected to compile such a list.
 
Maryland medical cannabis panel allows firm to compete again as charges linger against 2 former executives


A year ago Maryland medical marijuana regulators sought to deny a license to a company picked to grow the drug because there was “reasonable likelihood” it would not properly secure the medicine.

At the time, the Maryland Medical Cannabis Commission had become concerned about the firm, MaryMed, after two of its former executives were charged in Minnesota with felonies for allegedly transporting the drug from a Minnesota facility to one in New York state.

On Tuesday the commission reinstated the company into Maryland’s licensing process after an administrative judge concluded there is “no reasonable likelihood” that MaryMed had participated in smuggling a half-million dollars worth of cannabis oil from Minnesota to New York in December 2015.

Maryland regulators also had been concerned that MaryMed did not notify them quickly enough that its ownership structure had changed, separating the firm from its sister companies in Minnesota and New York and from the former executives each charged with two felony counts — medical director Dr. Laura Bultman and security director Ronald Owens.

Both are scheduled to stand trial in separate proceedings in November in Wright County District Court in Minnesota, according to a court official and online records.

Maryland’s commission in September announced it intended to deny MaryMed’s applications to grow, process and sell the drug in Maryland after it had already won pre-approval. But MaryMed requested a hearing.

Maryland Administrative Law Judge John J. Leidig ruled in May that MaryMed had responded “reasonably promptly” to commission requests about ownership structure and that “there is not a reasonable likelihood that medical cannabis was diverted from” Minnesota to New York. Leidig also found that the charges against the two former executives were based entirely on information provided by another former executive who had been fired, demonstrating “a motive to fabricate an allegation of cannabis diversion,” Leidig wrote.

The commission’s decision to reinstate MaryMed into the process for final approval comes with conditions — including additional monitoring by state regulators and a requirement that the firm retain and store video surveillance for a year instead of the 30 days required of other companies, said commission spokeswoman Jennifer White.

White said the commission had the ability to make a different decision “depending on the outcome” of the criminal trials against Bultman and Owens.

“The Commission will continue to monitor this situation carefully and expects to observe the highest level of quality, safety and security, as put forth by MaryMed in their initial applications,” according to the commission’s statement. “The Commission retains its broad investigatory authority to take further action, should new evidence come to light.”

Andrew Mangini, a MaryMed spokesman, thanked the commission for its decision.

“We look forward to completing final licensure approval to provide Maryland patients with high-quality medical cannabis products and the compassionate care that we are known for,” Mangini said. “We look forward to launching operations at our Dorchester County facility and bringing new, good-paying union jobs to the Eastern Shore.”
 
More Maryland medical marijuana firms approved as industry continues to grow

The final approval of eight new medical marijuana dispensaries on Thursday increased the size of Maryland’s retail market to 65 stores, more than halfway toward the 102 that have obtained pre-approval.

“We are making progress,” said Joy A. Strand, executive director of the Maryland Medical Cannabis Commission, at the panel’s Thursday meeting.

Revenue from dispensaries hit nearly $9 million in June, up from $2.6 million in January. Total sales for the past eight months stood at nearly $45 million.

The number of patients certified to obtain medical marijuana in Maryland jumped 27 percent — to 35,019 from 27,585 at the end of May.


Experts estimate that the number of patients typically equal 2 percent of a state’s population. For Maryland, which has a population of about 6 million, that would equate to 120,000 patients.

The state also continues to add medical providers who can prescribe the medication. The commission announced there are now 975 providers — primarily physicians. That’s up from 709 at the end of May.

The two areas with the most activity were Baltimore and Montgomery counties, which led the state in the number of patients and providers.

After the commission voted to approve six new dispensary licenses Thursday, attendees at the meeting broke out in applause. None were more excited than Mana Supply Company CEO Christopher Jensen, who let out a “woot” when the commission approved his firm’s dispensary license.

Mana — named after the Hawaiian word for “spiritual power” — has been working for nearly two years to get up and running in Anne Arundel County, where elected officials have erected barriers for the industry.

Jensen said he hopes his dispensary’s late-August opening in Annapolis, and accompanying outreach efforts such as outdoor yoga and a community garden, will help to “take away the stigma” of medical marijuana.
 
"Food sold at dispensaries would also have to be cross-regulated by the Maryland Office of Food Safety."

This was the ostensible reason for not allowing edibles...true food form edibles...they would have to pull another state agency into the mix and if they did, then we probably still wouldn't have an open med market yet.

The tablets, tinctures, and elixirs are WAY too expensive still but these can be considered "orally ingestable forms" rather than edible food forms.



Maryland's medical cannabis program technically bans food products — yet sells plenty of edible items

Dave hadn’t slept for more than three hours straight after a series of botched surgeries 18 years ago left him with chronic pain so intense it kept him awake at night. Relief was hard to come by — until he made a tray of marijuana-infused brownies. Half of a small fudgy square was enough to put him to sleep for 14 hours.

“It was the first thing I found that worked for the nerve pain,” he said.

Medical marijuana has since become part of the 62-year-old’s pain-management regimen, and he’s one of thousands of patients in Maryland who are ingesting cannabis extracts to treat their conditions.

For a state that has banned food from its medical cannabis program, Maryland provides plenty of ways for patients to ingest the drug. Patients won’t find pot brownies on local dispensary shelves, but a gray area in the law allows the shops to sell tinctures, tablets, powders and drinks alongside machines customers can use to make cannabis-infused oils. While state regulators worry the sale of cannabis-infused sweets would cross into recreational practice, they say they are working to better define which edibles are appropriate for the state’s medical market as demand for such products flourishes.

[Elderly patients are] not interested in developing necessarily a lifestyle of ... buying a lot of pipes and bongs. — James Hendricks, manager of Maggie’s, a Hampden dispensary
It’s easy to see why some patients prefer ingesting marijuana extracts to smoking it. It’s a discreet alternative that provides patients a more precise method of dosing. The drug’s effects take more time to activate when it’s ingested, but they also last longer.

Maryland is one of 30 states, plus Washington, D.C., that have a regulated medical marijuana market. Nine of those states also allow the recreational use of marijuana. Some states, such as Ohio, permit cannabis-infused foods as part of their medical marijuana programs. Others, like Arizona, do not allow the sale of any edible forms of the drug.

When medical marijuana first hit Maryland’s market in December, the only infused products available were vape pens. Product lines have since expanded, coinciding with an increase in the number of patients, growth in the number of operating dispensaries and a boost in medical cannabis sales. Maryland dispensaries sold 15,317 infused products — items other than dried marijuana including edibles, vape cartridges and patches — in December. By July, that figure increased five-fold to 77,216 products sold in the month.

Monthly dispensary sales topped $9.6 million in July, up from $1.8 million in December, according to data from the Maryland Medical Cannabis Commission. Dried marijuana still dominates sales, but dispensary owners and managers say patients can’t get enough of ingestible products.

For a first-time visitor walking into Pure Life Wellness, the range of products at the Federal Hill dispensary is surprising. Edible items, vape cartridges and weed journals line the shop’s shelves. The faint scent of marijuana hangs in the shop, and dried leaves sit in jars under glass.

Jackie Doloway, owner of Pure Life Wellness, showcases a variety of tablets made by Dixie, a national brand of infused cannabis products, that she says are a favorite among customers. Some of the tablets calm anxiety; others have energizing effects.




“They’re great just for anyone who’s battling … insomnia or anxiety throughout the day,” Doloway said.

Lori Dodson, deputy director for the Maryland Medical Cannabis Commission, said the commission wants to make more of those products available to give patients options for medicating.

Food is excluded from the local market because the commission does not want to conflate the medical intent of the state’s marijuana program with the drug’s recreational allure. Butt the state is looking to revise language in the law to better define what cannabis products are considered food, Dodson said.

Neither Dodson nor dispensary owners could point to the line between prohibited foods and legal edible products. Does a chewable tablet qualify as food? Is an elixir a drink?

“A lot of it has to do with marketing and education, really treating these products as medicine,” said Matt Kirby, a partner in Remedy, a Columbia dispensary.

Kirby said patients often ask about the edibles available at Remedy, and he knows a number of patients who make their own edibles using dried flowers to infuse oils. The Livo machine is a popular appliance sold at Remedy and other dispensaries that infuses fats with cannabis extracts.

750x422

After the Maryland medical cannabis industry launched in late 2017, business grew quickly. Baltimore County has nine dispensaries, two of which are Curio Wellness and AmediCanna Dispensary.

“It’s like a Mr. Coffee for cannabis oil,” Kirby said.

Customers can use the oils to make anything from salad dressing to granola — foods dispensaries don’t currently supply.

“Long gone are the days of, like, your stinky brownies,” Doloway said.

For Dave, cannabis is one of the few pain relievers he’s found that has lasting effects — particularly when eaten. At his request, The Baltimore Sun is using his first name only to protect his privacy.

“I started researching this because I couldn’t find any pain relief anywhere else,” the Baltimore resident said.

Nearly two decades ago — before medical marijuana was available in Maryland — a friend sent him cannabis oil from California, and he began eating it in pea-sized drops.




Some users can go wrong by ingesting too much medical marijuana before they feel its effects. But the edible products at local dispensaries come with specific dosing instructions.

Dispensary employees also advise patients to “start low and go slow.”

“Cannabis is not a one-size-fits-all medicine. It’s not, ‘Take two Tylenol and like call me tomorrow,’” Doloway said. “Everybody’s body is different. Everybody’s tolerance is different. It could take a couple different tries and a couple different things to find what works for you.”

James Hendricks, manager of Maggie’s, a Hampden dispensary, said edibles allow patients to dose more precisely than smoking or vaping — down to tenths of milligrams.

“We also have a lot of elderly folks who are used to taking pills and tablets, so this is almost exactly what they want,” Hendricks said. “They want to come in and say, ‘Give me something to take in the morning, and then in the afternoon and be done.’ They’re not interested in developing necessarily a lifestyle of ... buying a lot of pipes and bongs.”

More medical marijuana patients continue to register in Maryland. By Aug. 9, Maryland had 36,836 patients certified to receive medical marijuana, with 15,956 patients pending approval by the commission.




Patients like Dave crave more edibles. But they are not cheap. For instance, at Pure Life Wellness, Dixie’s packs of 20 tablets go for $20-$40; elixir bottles range from $28-$50 each; and tinctures cost $40-$90. Medical marijuana is not covered by insurance.

“I don’t think it’s going to be for everybody. I don’t know if it’s going to be for me in total — certainly not at current prices,” Dave said. “Right now if I was to stop taking any of my $10 a month prescriptions, I would have to spend $500 to $600 a month at the dispensary.”

Hendricks, who previously worked in Colorado’s weed industry, said products in Maryland are more expensive and less potent than in other states.

“Part of it probably has to do with: This is a brand new industry here, and you want to be more on the conservative end,” Hendricks said.

He said many patients at Maggie’s have been surprised to learn that Maryland doesn’t allow more edibles. But it’s unlikely other infused edibles will be sold at dispensaries without a legislative change. Food sold at dispensaries would also have to be cross-regulated by the Maryland Office of Food Safety.

Cookies and candy infused with cannabis extracts begin to clearly cross a line into the recreational market, Dodson said.

”While those are sometimes more appealing to patients, we also have to be very careful because now you’re appealing to a younger population,” Dodson said. “We have to be careful that we’re not getting product into the wrong hands.”
 
Software to Regulate Legal Marijuana Is Just as Error-Prone as Other Government Software
That can hurt businesses—and patients in need of pain relief.

Aaron Shepherd took a job at Greenwave Dispensary in southern Maryland in mid-May. A registered medical cannabis patient himself—he says the herb helped him kick an addiction to opioids years ago—he wanted to help others heal.

The gig proved so frustrating he quit after six weeks. Greenwave wasn’t the problem—it was Maryland’s mandatory cannabis-tracking Metrc software, which checks a patient’s prescription and purchase history at every sale. Metrc was repeatedly bogged down with user traffic, sometimes for hours. Patients sat waiting, and some who traveled some distance drove home empty-handed.

The final straw was when a woman using a wheelchair waited more than an hour to buy some cannabis, to no avail. Irritated, she and her husband left so she could get home to take her other meds, Shepherd says. “It practically put me in tears.”

Maryland is among 30 states so far that have legalized recreational or medical marijuana, and the vast majority of them require close tracking—known as “seed to sale”—of the plant. Maryland is also one of 10 states (plus D.C.) that are using Metrc, a product of Franwell. Seven others use software from Florida-based BioTrackTHC, and two, Pennsylvania and Washington, have signed up with MJ Freeway, software made by Denver-based Leaf Data Systems.

Each company helps regulators trace the cannabis moving through their borders—everything from microchipped pot plants to concentrates and buds sold at dispensaries. Retailers can generally use different software to ring customers up, but it’s on them to share the sales and inventory data with regulators to show they’re complying with state law. States have adopted the seed-to-sale model to ensure product safety and show they can keep their weed away from the larger, more entrenched black market.

But when the software doesn’t perform, the industry and its customers suffer. In 2018, in addition to rejecting patients, glitches caused by high levels of user traffic left dispensaries in Maryland unable to make transactions, costing them significant amounts of money, retail managers said. In 2017, Oregon’s marijuana growers and distributors complained of spending valuable man-hours updating inventory in Metrc and dealing with slow connections during peak harvest season. MJ Freeway’s glitches in Pennsylvania and Washington have halted commerce for dispensaries, and the company has suffered multiple hacks and security breaches, plus a troubled, months-delayed launch in Washington earlier this year. Before inking a deal with MJ Freeway, Washington worked with BioTrackTHC for four years, but growers bemoaned performance issues and lacking functionality.

Screw-ups with government-contracted software are nothing new. Few will forget the disastrous 2013 launch of healthcare.gov, a platform designed by 55 contractors without any coordinated leadership on the project. Companies that designed platforms to administer benefits have caused crises, like Deloitte failing to process thousands of applications for food stamps, welfare, and more in Rhode Island last year, or Accenture creating a 30,000-plus household backlog for food stamps in North Carolina because of a software glitch. Larger jurisdictions like California and Canada have dealt with the fallout from privately contracted software failing to properly deliver employees’ paychecks.

The cannabis industry, however, is using software to make its case to exist. Each state is part of a national trial experiment to show it can bring in tax dollars from a federally banned but widely used drug, all while keeping it from feeding the thriving black market. Obama-era guidance from 2013, since rescinded by Jeff Sessions, essentially told states that if they “implemented strong and effective regulatory and enforcement systems” to monitor their legal weed, they were safe from federal punishment. But if oversight lapses and the trials fail—such as through large amounts of cannabis leaking into the illicit economy—Sessions’ Justice Department has more of an excuse to crack down on cannabis and quash the experiment altogether.

So what are states doing to address software blunders? In July, Metrc sourced Maryland’s outage problems to an automated tool, an application programming interface, that checks each patient’s prescription limit and purchase history for every sale. The API automatically stopped patients from buying more than they’re allowed—say, a cap of 120 grams in 30 days. But Metrc said it was being used “excessively and in ways that neither Metrc nor the state had anticipated” in a July 3 memo. Joy Strand, executive director of the Maryland Medical Cannabis Commission, said disabling it would stem the disruptions.

The upside: Regulators said outages tapered off shortly after the API was removed. But Maryland disabled a tool meant to mitigate human error. Limit checks are legally required to make a sale, so dispensary staff have since been manually typing each patient’s information into a state database, all on the honor system. Skipping that step presents a new risk for diversion, in which legally grown marijuana slips into the illicit market. A dispensary can also face fines or stiffer penalties for violating state rules.

And what’s more, outages with Metrc are still happening when many patients are making purchases at once across the state, patients and retailers say. One dispensary manager said they had three outages in one week in late August and earlier this month, each lasting more than an hour and halting sales altogether.

Just last week, the state provided a temporary fix to help patients during outages. Under a new exception, dispensaries will be allowed to sell a patient a small amount—up to 12 grams of marijuana or 2.5 grams of concentrates—when Metrc isn’t working, so they’ll no longer have to turn patients away. But it still doesn’t address the overall problem: the glitches caused by overwhelming traffic.

Ben Curren, CEO of Green Bits, whose point-of-sale platform is used by about half of Maryland’s dispensaries, says that, rather than remove the safeguard of the API, the state should pay for an extra server or bandwidth with Metrc to address the traffic glut. Colorado did so proactively in December 2017, preparing to handle increased server traffic in the future, regulators say.

In July, Strand told me that Maryland and Metrc were working on “a long-term solution” but had “nothing specific” to share. She acknowledged human error is inevitable in a manual process but assured that “we’re going to work with the dispensaries” if they’re found to have made a mistake. Asked for comment, Metrc Executive Director Scott Denholm said in an email that the company doesn’t discuss specific state programs.

Numerous Washington state cannabis businesses and observers have remained wary of MJ Freeway after the system’s flawed kickoff. It was “hands down, perhaps second only to the launch of healthcare.gov, the worst product launch that I’ve ever seen,” said Gregory Foster, a representative for the Cannabis Alliance industry group on the state Liquor and Cannabis Board’s Traceability Advisory Committee. While MJ Freeway spokeswoman Jeannette Horton says there wasn’t “any period where anyone couldn’t do business” in the days after the launch, some shops and growers said the software was muddling shipping orders, causing delays and supply issues for stores and costing producers revenue.

Furthermore, MJ Freeway’s platform in Washington doesn’t help growers manage inventory, so they must now use third-party software that reports data into the tracking system. Nick Cihlar, co-owner of the grower Subdued Excitement in Ferndale, Washington, has seen discrepancies with strain names, product types, and stock tracking. “We have no way of knowing if our current inventory is accurate.”

Washington and MJ Freeway released a software update in late August that regulators say should address frustrations. The state is now proceeding with added caution: MJ Freeway could face penalties if it doesn’t meet deadlines for three more software updates this year, Liquor and Cannabis Board spokesman Brian Smith said. The state and MJ Freeway recently renewed their contract, but it was for six months instead of a full year.

Colorado, the first state to sell legal recreational pot, has been a comparative success story since its industry launched in January 2014. The state uses Metrc, and Kyle Lambert, deputy director of the Department of Revenue’s Marijuana Enforcement Division, says he’s unaware of “any kind of system shutdowns or interruptions for any period of time” since then. He credits Colorado’s solid record with software in part to the state’s Metrc user group, which brings together reps from the state, Franwell, licensed businesses, and affiliated software providers. (Oregon also maintains a Metrc user group.)

Colorado hasn’t dodged complaints altogether, of course. Dispensaries grumbled early on about having to manually enter sales figures into both Metrc and their own point-of-sale software, costing time and labor and risking human error. But Lambert says the state, Metrc, and third-party firms fixed that issue by automating the task through an API. (Colorado hasn’t faced the same problems as Maryland because they use slightly different systems, due to different state regulations.)

Another lingering thorn: Metrc requires growers in all 10 client states and D.C. to buy radio-frequency identification tags to track plants. The tags cost 45 cents per plant and 25 cents per batch, according to the company’s website, and can only be used once. That adds up for growers. Marijuana Enforcement Division Director Jim Burack acknowledges the grievances, but says they ensure product safety and protect public health.

Other industries like food and pharmaceuticals have proven they can reliably trace their products, pushed by federal policymakers and consumers to improve supply-chain tracking. Pointing to agricultural sectors’ working traceability systems, Foster remains optimistic that cannabis will eventually catch on. “Once there is increased consumer awareness and organized pressure, it’s going to have to be a problem that is solved to everyone’s satisfaction.”

And while the industry may not be able to draw the same caliber of tech talent and investment as other sectors right now—“well-known corporations that do this kind of work … would never touch a contract like this because it’s marijuana,” Smith says—seed-to-sale is still in its infancy. There will be even more trials as other states legalize. The federal government will eventually be pressured to step in and set uniform rules for tracking cannabis.

“You have to ask yourself, what in the hell is gonna happen when it goes nationwide?” says Donald Morse, chairman of the Oregon Cannabis Business Council. “How are we gonna track a delivery from Oregon to Indiana if Indiana is using a different system than Oregon?”

As important as it is for seed-to-sale platforms to serve the industry, patients and customers are the backbone of this whole legal pot idea. At best, a software outage is inconvenient for the casual user in a recreational-friendly state. At worst, it betrays the patient who uses marijuana as medicine.

Dustin Dixon of Catonsville, Maryland, falls in the latter group. He uses marijuana to treat insomnia, anxiety, and depression. He usually looks to flower—the weed medium you’re likely most familiar with—and sometimes picks up half-ounces to save time on runs to the dispensary. He waited out several backups with Metrc this summer, including one that lasted an hour, eating up his entire lunch break.

He says the recent change allowing dispensaries to sell small amounts of cannabis when Metrc is bogged down is “a positive step in the right direction” and “definitely shows [regulators] do care” about Maryland’s roughly 59,000 (and counting) registered patients. But it’d be even better to see the state address underlying technical issues with Metrc altogether, he says.
 
This approach is not helpful to our cause, IMO.


Demonstration Against Anti-Weed Maryland Politician Ends in Altercation
A Maryland cannabis activism group staged a demonstration, only to have it end in a physical altercation.

A pro-cannabis protest outside Maryland Republican Rep. Andy Harris’ office in Washington, D.C. turned into a scuffle Tuesday, according to press and social media reports. Demonstrators reportedly tried to follow Harris into his office, apparently erupting into a shoving match from each side of the door as the congressman tried to hold it closed.

News of the altercation first broke on Twitter, when Jennifer Bendery, a senior political reporter for the Huffington Post, wrote on Twitter that an officer from the Capitol Police had told her an altercation had occurred and that Harris had been “assaulted by demonstrators.”

“Another little detail, per Cap Police officer: Harris was trying to hold his office door closed but was not successful. Also the demonstrators were smoking weed,” Bendery added later.

During the protest, Rachel Ramon Donlan, an activist with the group Maryland Marijuana Justice (MDMJ), smoked marijuana in a hallway of the Longworth House Office Building at the U.S. Capitol. Officers from the Capitol Police then shut down the hallway and later removed Ramone in handcuffs and a wheelchair.


Donlan, of Washington, D.C., and Kristin Furnish from Salisbury, Maryland were charged with possession and consumption of marijuana in a public space, according to Capitol Police.

Protesters Advocate for Cannabis As an Alternative to Opioids
Other protestors holding signs about the opioid crisis and resulting deaths in Maryland also participated in the demonstration. MDMJ is a new activist group of “Maryland Voters opposed to marijuana laws that lock people up for growing a beneficial plant. We are fighting for home cultivation and full legalization,” according to its Twitter page. MDMJ advocates for cannabis as an alternative to opioids and includes several members who have been personally affected by the nationwide epidemic of overdoses from the powerful painkillers.

Furnish, a co-founder of the group, told reporters that Harris and other Republicans are impeding cannabis legalization while people in Maryland and across the country are dying needlessly.


“Citizens of Maryland and the District of Columbia are tired of Andy Harris turning a blind eye to a safe solution to the opioid crisis,” said Furnish. “Marijuana is a proven pain management alternative to opioids, but in Maryland, we have only seen an increase in opioid-related deaths since Harris was first elected in November 2010. Members of the GOP Congress led by Congressman Harris remain willfully ignorant and outright hostile to cannabis reform. This must stop!”

The activist group also planned additional protests at Rep. Harris’ other congressional offices and stage mock overdoses. Demonstrations were scheduled at 3 p.m. at his Salisbury, Maryland, office and at 4:20 p.m. at his office in Bel Air, Maryland. The group planned the demonstrations against Harris after he affirmed his opposition to the legalization of cannabis at a town hall meeting in Salisbury in August.

In her statement to the media, Furnish said that Harris was unwilling to engage in a dialogue about cannabis policy reform.


“These protests wouldn’t be necessary if someone would just sit down with us advocates. We’ve tried to meet with Rep. Harris and they won’t get back with us,” Furnish said.
 
"Food sold at dispensaries would also have to be cross-regulated by the Maryland Office of Food Safety."

This was the ostensible reason for not allowing edibles...true food form edibles...they would have to pull another state agency into the mix and if they did, then we probably still wouldn't have an open med market yet.

The tablets, tinctures, and elixirs are WAY too expensive still but these can be considered "orally ingestable forms" rather than edible food forms.



Maryland's medical cannabis program technically bans food products — yet sells plenty of edible items

Dave hadn’t slept for more than three hours straight after a series of botched surgeries 18 years ago left him with chronic pain so intense it kept him awake at night. Relief was hard to come by — until he made a tray of marijuana-infused brownies. Half of a small fudgy square was enough to put him to sleep for 14 hours.

“It was the first thing I found that worked for the nerve pain,” he said.

Medical marijuana has since become part of the 62-year-old’s pain-management regimen, and he’s one of thousands of patients in Maryland who are ingesting cannabis extracts to treat their conditions.

For a state that has banned food from its medical cannabis program, Maryland provides plenty of ways for patients to ingest the drug. Patients won’t find pot brownies on local dispensary shelves, but a gray area in the law allows the shops to sell tinctures, tablets, powders and drinks alongside machines customers can use to make cannabis-infused oils. While state regulators worry the sale of cannabis-infused sweets would cross into recreational practice, they say they are working to better define which edibles are appropriate for the state’s medical market as demand for such products flourishes.

[Elderly patients are] not interested in developing necessarily a lifestyle of ... buying a lot of pipes and bongs. — James Hendricks, manager of Maggie’s, a Hampden dispensary
It’s easy to see why some patients prefer ingesting marijuana extracts to smoking it. It’s a discreet alternative that provides patients a more precise method of dosing. The drug’s effects take more time to activate when it’s ingested, but they also last longer.

Maryland is one of 30 states, plus Washington, D.C., that have a regulated medical marijuana market. Nine of those states also allow the recreational use of marijuana. Some states, such as Ohio, permit cannabis-infused foods as part of their medical marijuana programs. Others, like Arizona, do not allow the sale of any edible forms of the drug.

When medical marijuana first hit Maryland’s market in December, the only infused products available were vape pens. Product lines have since expanded, coinciding with an increase in the number of patients, growth in the number of operating dispensaries and a boost in medical cannabis sales. Maryland dispensaries sold 15,317 infused products — items other than dried marijuana including edibles, vape cartridges and patches — in December. By July, that figure increased five-fold to 77,216 products sold in the month.

Monthly dispensary sales topped $9.6 million in July, up from $1.8 million in December, according to data from the Maryland Medical Cannabis Commission. Dried marijuana still dominates sales, but dispensary owners and managers say patients can’t get enough of ingestible products.

For a first-time visitor walking into Pure Life Wellness, the range of products at the Federal Hill dispensary is surprising. Edible items, vape cartridges and weed journals line the shop’s shelves. The faint scent of marijuana hangs in the shop, and dried leaves sit in jars under glass.

Jackie Doloway, owner of Pure Life Wellness, showcases a variety of tablets made by Dixie, a national brand of infused cannabis products, that she says are a favorite among customers. Some of the tablets calm anxiety; others have energizing effects.




“They’re great just for anyone who’s battling … insomnia or anxiety throughout the day,” Doloway said.

Lori Dodson, deputy director for the Maryland Medical Cannabis Commission, said the commission wants to make more of those products available to give patients options for medicating.

Food is excluded from the local market because the commission does not want to conflate the medical intent of the state’s marijuana program with the drug’s recreational allure. Butt the state is looking to revise language in the law to better define what cannabis products are considered food, Dodson said.

Neither Dodson nor dispensary owners could point to the line between prohibited foods and legal edible products. Does a chewable tablet qualify as food? Is an elixir a drink?

“A lot of it has to do with marketing and education, really treating these products as medicine,” said Matt Kirby, a partner in Remedy, a Columbia dispensary.

Kirby said patients often ask about the edibles available at Remedy, and he knows a number of patients who make their own edibles using dried flowers to infuse oils. The Livo machine is a popular appliance sold at Remedy and other dispensaries that infuses fats with cannabis extracts.

750x422

After the Maryland medical cannabis industry launched in late 2017, business grew quickly. Baltimore County has nine dispensaries, two of which are Curio Wellness and AmediCanna Dispensary.

“It’s like a Mr. Coffee for cannabis oil,” Kirby said.

Customers can use the oils to make anything from salad dressing to granola — foods dispensaries don’t currently supply.

“Long gone are the days of, like, your stinky brownies,” Doloway said.

For Dave, cannabis is one of the few pain relievers he’s found that has lasting effects — particularly when eaten. At his request, The Baltimore Sun is using his first name only to protect his privacy.

“I started researching this because I couldn’t find any pain relief anywhere else,” the Baltimore resident said.

Nearly two decades ago — before medical marijuana was available in Maryland — a friend sent him cannabis oil from California, and he began eating it in pea-sized drops.




Some users can go wrong by ingesting too much medical marijuana before they feel its effects. But the edible products at local dispensaries come with specific dosing instructions.

Dispensary employees also advise patients to “start low and go slow.”

“Cannabis is not a one-size-fits-all medicine. It’s not, ‘Take two Tylenol and like call me tomorrow,’” Doloway said. “Everybody’s body is different. Everybody’s tolerance is different. It could take a couple different tries and a couple different things to find what works for you.”

James Hendricks, manager of Maggie’s, a Hampden dispensary, said edibles allow patients to dose more precisely than smoking or vaping — down to tenths of milligrams.

“We also have a lot of elderly folks who are used to taking pills and tablets, so this is almost exactly what they want,” Hendricks said. “They want to come in and say, ‘Give me something to take in the morning, and then in the afternoon and be done.’ They’re not interested in developing necessarily a lifestyle of ... buying a lot of pipes and bongs.”

More medical marijuana patients continue to register in Maryland. By Aug. 9, Maryland had 36,836 patients certified to receive medical marijuana, with 15,956 patients pending approval by the commission.




Patients like Dave crave more edibles. But they are not cheap. For instance, at Pure Life Wellness, Dixie’s packs of 20 tablets go for $20-$40; elixir bottles range from $28-$50 each; and tinctures cost $40-$90. Medical marijuana is not covered by insurance.

“I don’t think it’s going to be for everybody. I don’t know if it’s going to be for me in total — certainly not at current prices,” Dave said. “Right now if I was to stop taking any of my $10 a month prescriptions, I would have to spend $500 to $600 a month at the dispensary.”

Hendricks, who previously worked in Colorado’s weed industry, said products in Maryland are more expensive and less potent than in other states.

“Part of it probably has to do with: This is a brand new industry here, and you want to be more on the conservative end,” Hendricks said.

He said many patients at Maggie’s have been surprised to learn that Maryland doesn’t allow more edibles. But it’s unlikely other infused edibles will be sold at dispensaries without a legislative change. Food sold at dispensaries would also have to be cross-regulated by the Maryland Office of Food Safety.

Cookies and candy infused with cannabis extracts begin to clearly cross a line into the recreational market, Dodson said.

”While those are sometimes more appealing to patients, we also have to be very careful because now you’re appealing to a younger population,” Dodson said. “We have to be careful that we’re not getting product into the wrong hands.”

I’ve found edibles in DC to be hit or miss. Some of the tinctures suck. I’m going to buy a stronger tincture later this week to see how it is. At $120 a bottle it better be solid.

The chocolates have been ok. However, I once ate 1.5 (15mg thc) and felt nothing. I’m a bit of a lightweight too. The others in the bag packed a really good punch.

I’m going to try the “Buttah” too. Although I suspect I could do better on my own with my Ardent Lyft and MBM and some unsalted butter or just coconut oil.
 
I’ve found edibles in DC to be hit or miss. Some of the tinctures suck. I’m going to buy a stronger tincture later this week to see how it is. At $120 a bottle it better be solid.

The chocolates have been ok. However, I once ate 1.5 (15mg thc) and felt nothing. I’m a bit of a lightweight too. The others in the bag packed a really good punch.

I’m going to try the “Buttah” too. Although I suspect I could do better on my own with my Ardent Lyft and MBM and some unsalted butter or just coconut oil.
I do get Tincture here in MD from Liberty....its ok as an addition for those nights I need a bit extra. Sublingual for at least a minutes, then swallow.
 


Maryland puts a hold on medical marijuana from Lothian grower


750x422


State officials have told marijuana dispensaries and processors not to accept products from a Lothian growing facility.

The Maryland Medical Cannabis Commission has placed an “administrative hold” on products from ForwardGro.

Joy Strand, the commission’s executive director, said in a statement Wednesday the hold on ForwardGro’s products was “a precautionary measure” pursuant to a section of Maryland codes and regulations regarding inspections.

While Strand did not comment as to the nature of the investigation, she cited part of Maryland code that states a possible suspension of product distribution if “an inspector has reasonable suspicion of an operational failure or of conditions that create a likelihood of diversion, contamination, or a risk to the public health.”

ForwardGro spokeswoman Vicki Bendure said Wednesday that plants had passed inspection numerous times. She said the company has not been informed of what the investigation is about and why its products are on administrative hold.

“We are really in the dark,” Bendure said. “We have no idea what’s going on.”




The commission announced in July it was investigating allegations the facility illegally used pesticides in growing cannabis plants later harvested for sale to patients. ForwardGro has denied the claims made by three former employees to the General Assembly.

ForwardGro is co-owned by Gary Mangum, a prominent supporter of Gov. Larry Hogan who served on Hogan’s inaugural committee and transition team.

The General Assembly adopted an amendment to a medical marijuana bill that allowed for the use of some pesticides. It directed the Department of Agriculture to create emergency regulations regarding allowed pest control by June 1.

Those rules went into effect in July, but it was not immediately clear what would be allowed by the commission under the new regulations.

The medical marijuana industry has had a tumultuous start in Anne Arundel County, as owners have been fighting litigation from their past businesses and county officials have been accused of trying to squeeze dispensaries into narrow corridors.

The wife of a physical medicine rehabilitation specialist who is being sued by the county for allegedly overprescribing opioid painkillers is a part-owner of Kind Therapeutics USA LLC, which has applied to open a dispensary off Generals Highway. The County Council passed a bill earlier this month that loosened restrictions on medical marijuana projects and included special exemptions for sites within industrial districts, like what Kind Therapeutics has proposed.

That bill followed complaints that county officials were effectively pushing out the medical marijuana industry. Some, including an owner of a Linthicum dispensary, said the county made such strict regulations around where the businesses could be developed that it became nearly impossible to find suitable sites away from schools and residences north of U.S. Route 50.

A part-owner of a proposed dispensary on West Street in Annapolis was sued by the Equal Employment Opportunity Commission after Hispanic employees at his previous car wash business claimed he and other employees treated them like personal servants, sometimes assigning male employees to do chores around their personal homes.
 
The Maryland Medical Cannabis Commission is as incompetent and clueless as the rest of the state government.

National cannabis companies trying to take over Maryland businesses.

National cannabis companies eager to expand their share of the growing U.S. medical marijuana industry are poised to acquire companies with Maryland licenses despite a state rule that limits such consolidation and a new law barring any ownership changes for another year.

A Baltimore Sun investigation has found that several out-of-state firms have told investors they are moving ahead with deals to take over Maryland marijuana companies by the end of this year.

For instance, Massachusetts-based Curaleaf, which has two of its own licenses in Maryland, has offered $30 million to acquire a small Frederick County company authorized to grow, process and sell cannabis.

Other large, national companies — MedMen, MPX and GTI — also have pending deals for Maryland firms. Their plans are raising concerns that companies are trying to monopolize the Maryland market.

And some question whether the Maryland Medical Cannabis Commission — which was unaware of three of the deals until notified by The Sun — is up to its task of regulating the industry.

“I don’t know how the commission is allowing this to happen,” said Del. Cheryl Glenn, a Baltimore Democrat who has worked to establish regulations overseen by the commission. “We are adamantly opposed to large out-of-state companies coming in and buying up licenses.”

A law signed in May “prohibits the flipping of any of the licenses,” Glenn noted. “This needs to cease and desist.”

The $30 million that Curaleaf has offered for HMS Health — a single company in a year-old Maryland industry that recorded just $67 million in sales over the first nine months of 2018 — shows how lucrative the state market is expected to become.




Maryland regulations allow companies to own no more than one license in each of the state’s three categories — growing marijuana, processing it into medical products and selling them from retail stores. And a new law that took effect May 15 imposed a moratorium on sales for at least another year, in part, to avoid the type of consolidation that companies are trying to execute.

The Maryland Medical Cannabis Commission says it does investigate ownership changes and can impose penalties, including revoking a license, if it discovers violations of those rules.

The commission acknowledges, however, that it knows of such transactions only if the licensed companies follow the state rules and report when someone acquires 5 percent or more of their ownership. Since May 15 the commission has responded that it will reject all such changes.

But some companies moving to enter the Maryland market have been structuring take-over bids as management agreements that give them nearly all of the revenues without actually owning the licensed firm, said commission spokeswoman Jennifer White.

For now such deals are not covered by state regulations and do not have to be reported, White said.

The commission was unaware of Curaleaf’s proposed acquisition of HMS Health and of the GTI and MPX deals until notified by The Sun, she added. MedMen notified the commission about its merger with PharmaCann, which currently holds a license to sell cannabis in Rockville. White said the commission will now investigate the deals involving MedMen, GTI and MPX.




White and state lawmakers said the General Assembly will address the possible loophole involving management agreements when it meets in January for its 2019 legislative session.

“When this is all said and done, every page of [state regulations] will have been deciphered to say exactly what was meant,” White said.

Del. Sandy Rosenberg, a Baltimore Democrat tapped by House Speaker Michael Busch to oversee the committee that recommended the moratorium law, said the state is trying to keep up with how companies are operating.

“We will clearly look at it again,” Rosenberg said. “This is an ongoing process. We need to respond to what people are doing in a way that furthers our policy goals.”

In June the commission warned companies to avoid deals that violate the state’s license limits.

The Sun reported a month later that several such deals were nonetheless in the works, spurring Rosenberg to ask the Maryland Attorney General’s office to clarify the commission’s authority to restrict such transactions. The attorney general’s office confirmed last month in a letter to Rosenberg that the commission can enforce both the moratorium law and the regulation limiting license ownership.

Since then The Sun has discovered several new deals through public records filed with the Canadian Securities Exchange. There are currently 121 cannabis companies that trade in Canada — which legalized all cannabis use last month — and 55 of them have operations in the United States, said exchange CEO Richard Carleton.




Most cannabis companies do not list on U.S. stock exchanges because marijuana is still illegal under federal law. Companies are going public to capitalize on investors’ enthusiasm for a nascent industry expected to generate $23 billion in North American sales within five years, according to analysts at Arcview Market Research.

In 2017, publicly-traded cannabis companies raised $2.9 billion to support their expanding operations, market analysts say.

Acquiring government licenses is essential for the companies to grow.

“Bigger companies are trying to expand their breadth by going after state licences,” said David Kretzmann, an analyst with Motley Fool who tracks the cannabis industry.

Because companies cannot transport marijuana across state lines, Kretzmann said they must “start from scratch” in each state — ideally by acquiring licenses to grow, process and sell. Such so-called “vertical integration” is essential to make these businesses profitable, since other laws restrict their ability to conduct traditional banking and deduct certain U.S. taxes.

Curaleaf, which is traded on the Canadian exchange, holds two of its own Maryland licenses: one to sell medical cannabis from a Reisterstown store and one to make products at an Allegany County facility. Curaleaf attained that processing license in 2017 by paying $2 million to acquire majority ownership of the former Maryland license holder, PharmaCulture, according to corporate records.

In an Oct. 26 filing with the Canadian exchange, Curaleaf reported that it has entered into a $30 million “purchase agreement” to acquire HMS Health LLC, a family-owned firm in Frederick County that holds Maryland licenses to grow marijuana, make products, and sell them from a Gaithersburg store. The deal also included taking over a second Gaithersburg store owned by MI Health, which is affiliated with HMS Health.

Once the “Maryland acquisition” is completed, Curaleaf “intends to build out its third dispensary and operate it in Gaithersburg,” the document states.

The disclosure states that Curaleaf is aware of Maryland’s limits on license ownership. The acquisition is “subject to regulatory approval” in a state where “no one company can directly own more than one license of the same class,” the disclosure states.




But it makes no mention of the moratorium on sales until at least December 2019 — a measure that became law months before Curaleaf says it entered into the HMS deal in August 2018. The acquisition is scheduled to close before the end of the year, according to the company disclosure.

The deal sheds light on what critics say is a loophole to take control of licenses through management agreements, rather than outright acquisitions. Curaleaf states that it controls new companies either “through the purchase of the business or control through a management agreement.”

A Curaleaf spokeswoman said in an email that the company’s “public disclosure should not be read to imply that they are planning to acquire ownership of licenses in violation of restrictions in MD law or of not complying with any approval or disclosure requirement.”

HMS Health was one of the first companies to emerge in Maryland’s new medical marijuana industry. It is run by a family team of Meher, Shakil and Haris Siddiqui that built their operation on a 150-acre former tree nursery. Their security director is former Frederick County Sheriff James W. Hagy.

Phone calls to the company and its executives were not returned.

Lawyers for several cannabis companies argue that Maryland’s regulations can be interpreted in different ways to support certain acquisitions. But the Maryland attorney general has confirmed the meaning of the rules as interpreted by the commission and state lawmakers.

“The intent was very clear,” said J. Darrell Carrington, executive director of Maryland Cannabis Industry Association, a trade group. “One of the fears that the General Assembly had was creating ‘Big Cannabis,’ of having monopolies.”

Companies that control too many operations would be able to sell their products more cheaply to their stores while inflating prices for competing dispensaries, Carrington said.




The Maryland Attorney General’s office agreed in a letter to Rosenberg. Assistant Attorney General Sandra Benson Brantley wrote that allowing companies to control multiple licenses could “put smaller operations out of business and risks the creation of monopolies.”

When The Sun reported on such deals in July, Chicago-based Green Thumb Industries, or GTI, had told investors it held “controlling ownership over five retail dispensaries” in Anne Arundel, Harford and Montgomery counties.

GTI reiterated its Maryland footprint just last month in an Oct. 10 prospectus filed with Canadian regulators to raise $88 million. The company says it “holds” or operates dispensary and processing licenses in Joppa, Centreville, Silver Spring and Bethesda, and is set to close two dispensary deals in Abingdon and Gambrills.

The deal for the Abingdon store, currently run by Revolution Maryland Retail, illustrates the use of management agreements. In its disclosure, GTI states that the deal is a “management services agreement” that includes “purchasing of 100 percent” of Revolution for cash. The sale is anticipated to close before the end of this year, “subject to applicable regulatory approvals,” the document states.

“GTI is fully compliant with all Maryland laws and regulations” — including the two-year moratorium, said company spokeswoman, Linda Marsicano.

Also in early October, MedMen, a Los Angeles company that trades on the Canadian exchange, announced a stock deal worth $682 million to acquire Chicago-based PharmaCann, which owns the Verilife store Rockville in Montgomery County. The combined company now holds licenses in Maryland and 11 other states.

And in late October, MPX Bioceutical Corp. of Toronto announced that the company has opened three Health for Life stores in Baltimore, Nottingham and Bethesda.

MPX “manages three full service dispensaries and one producer in Maryland,” the company said in records filed with the Canadian exchange, using language that hints at a management agreement.

That announcement came shortly after the company merged with another national firm to form an operation spanning 10 states with 56 cannabis stores, including in Maryland.

The merger establishes what the new company calls “super-regional footprints in both the eastern and western United States.”
 
Prices are coming down. Saw a BF sale on flower....seven selected strains for $150/oz which is WAY lower than when the market opened. Most had THC in the teens, but still...ain't bad. Most top shelf flower is still going for $300-360 which is down from $440 or higher when it first opened. And, they will come down more.

Maryland medical marijuana sales surpassing forecast

Medical marijuana sales in Maryland are surpassing a previous forecast and could reach $100 million this year.

The Baltimore Sun reports that medical marijuana sales totaled $67 million for the first nine months of 2018.

A market research firm predicted last year that the state’s sales in 2018 would be about $46 million. New Frontier Data Senior Economist Beau Whitney said sales could now hit $100 million in December.

State lawmakers have expressed concern that the state’s new medical marijuana industry could be dominated by a handful of big companies. Lawmakers approved legislation earlier this year aimed at improving diversity in the industry by increasing the number of grower licenses and licenses to process marijuana.
 

Edibles and Emerging Cannabinoids: News From Maryland’s Medical Cannabis Forum


As Maryland approaches the first anniversary of legal medical marijuana sales, the state system is showing signs of maturing. Roughly 35,000 patients are now registered, 69 dispensaries are licensed, and even infused edibles could be available to patients before long.


The inaugural Maryland Medical Cannabis Forum, held earlier this month in Baltimore, discussed these and other developments as part of its goal to provide up-to-date information to Maryland doctors about the state of medical cannabis research and practices.

Here were our top 7 takeaways:

1. Edibles Are (Probably) Headed to Maryland Dispensaries
Joy Strand, executive director of the Maryland Medical Cannabis Commission, hit a hot topic for patients when she acknowledged that many don’t want to smoke or vape cannabis and would instead prefer to consume infused edibles. Dispensaries are especially seeing this with elderly patients, she said. While the commission is actively working on a program to allow edibles, though, it’s not yet clear when products will be approved. Officials are still working out the details.


RELATED STORY
Recipe: How To Make Basic Cannabis-Infused Butter

2. Emerging Cannabinoids Are on the Rise
Sure, you’re probably already familiar with THC and CBD. But Jokūbas Žiburkus, a neuroscientist and the CEO of Canntelligence, a research center at the University of Houston, argued that emerging cannabinoids are the future of medical cannabis. Cannabinoids act as keys that fit into the various locks of our natural endocannabinoid systems, he explained. Less common cannabinoids, such as CBG, CBN, CBC, and CBDV, could offer a range of unexplored therapeutic benefits.


RELATED STORY
List of Major Cannabinoids in Cannabis and Their Effects

3. Terpenes Are Helping to Categorize Cannabis
Our sense of smell is an age-old way to determine if a cannabis strain is right for you, Žiburkus explained, and there’s a good reason for that. Nearly all of a strain’s scent is a result of its terpenes, the aromatic oils that imbue cannabis with an array of flavors. Beyond taste and odor, though, these terpenes likely play a key role in the effects a particular cannabis strain can have on your body and brain.

Žiburkus believes that terpenes will soon be the differentiator among strains, replacing the traditional indica–sativa divide. He foresees dispensaries arranging products by terpene type, allowing patients to choose based on terpenes associated with the kind of relief they are seeking.


RELATED STORY
Your Favorite Cannabis Strains and Their Main Terpenes

4. Cannabis Is Going Global
With Canada’s legalization of adult-use cannabis, Mexico’s recent Supreme Court ruling overturning prohibition, the approval of medical cannabis in the UK, and further developments in Germany and other parts of the world, Žiburkus sees a global paradigm shift unfolding. As a part of that shift, he said, the way global consumers use cannabis could change. Reintroducing the hemp plant back into our food chain, for example, could help realize certain health benefits. According to Žiburkus, endocannabinoid system deficiencies—such as migraines, fibromyalgia, irritable bowel syndrom, neurotransmitter diseases, and epilepsy—may be caused by the fact that we consume far less hemp (as food) as we used to.


RELATED STORY
Cannabis Legalization Introduced in Mexico Senate

5. Cannabis Is Being Used to Treat Addiction and Prevent Opioid Dependency
Dr. Dustin Sulak, a Maine-based physician, explained the role cannabis can play in helping reduce dependencies on opioids and other prescription medications. While cannabis has recently come into the spotlight as an alternative for those struggling with opioid addiction, Sulak instead focused on the synergistic effects of prescribing opioids and cannabis for pain. Because the body’s opioid and cannabinoid receptors are near each other, he said patients can sometimes lower their opioid dose by adding a complementary cannabis dose. The practice allows patients to take smaller amounts of opioids by turning an otherwise insufficient dose of opioids into a viable option for pain reduction. Additionally, Sulak said, patients don’t build up the same tolerance over time that they do when using opioids alone.


RELATED STORY
Cannabis as an Opioid Exit: 5 Real-Life Stories

6. Elderly Patients Will Drive The Next Medical Cannabis Wave
Tim Seymour, an investment expert and CNBC personality, led a panel discussion with about trends that medical professionals are seeing in cannabis patients. Sulak, who has worked with 18,000 cannabis patients, said that he initlally saw many coming in for pain reduction, followed by a shift toward pediatric neurology. Today, he said, he encounters a large number of patients who are elderly. Many of these older patients are seeking to replace other medications or manage issues such as pain management, Alzheimer’s disease, or end-of-life anxiety.


RELATED STORY
Study Finds Most Cancer Patients Want MMJ Info, But Few Get It

7. The Knowledge Gap Remains
As doctors in Maryland increasingly open up to the medical benefits of cannabis, there’s a persistent gap in communication and education among patients, physicians, and dispensaries, panelists said. With cannabis not traditionally included in medical training and federal prohibition having long stymied the bulk of clinical research, physicians can understandably feel unprepared or hesitant to address the use of cannabinoids. Another challenge is that cannabis is a particularly individualized treatment, with no turnkey treatment regimen or standard dosing. And because cannabis isn’t dispensed through regular pharmacies, there’s no guarantee that the patient will even have access to doctor-recommended products, such as high-CBD strains. The MMCC has been recognizing these gaps over the past year, panelists said, and is currently developing programs to address them. Regulators are also working to get a clinical director in each dispensary and said to expect more Maryland cannabis legislation in the coming year.
 
Maryland is the epitome of the nanny state whose first impulse is that all possible risks and independent citizen behavior must be rigidly controlled via government.....sort of ignoring how incompetent our state government is, actually.

Oh, by the by....both Big Pharma and Big Liquor adverts are free to run here in the Socialist State of Maryland. This look familiar? Ooooooh, but what about the children...the children...the children that are constantly used as justification for the self-righteous interventionist actions of our state government.

4061353e7304cd0010e9021ddca55899.jpg


Maryland effectively bans all forms of marijuana advertising

Last week, Maryland’s body of cannabis policymakers, the Maryland Medical Cannabis Commission, unanimously decided to place multiple rigid regulations on advertisements for cannabis products and services. While the regulations are called “restrictions” in the official ruling, there are so many that the state has effectively banned all forms of advertising for anything related to medical cannabis consumption.

The New Rules
According to the new rules, those involved in Maryland’s medical cannabis industry are in a bind when it comes to getting the word out about their products and services. Here are all the channels through which medical marijuana may not be advertised:

  • Billboards
  • Radio or television
  • Public property
  • Print publications, like newspapers or magazines, “unless at least 85 percent of the audience is reasonably expected to be 18 years of age or older, as determined by reliable and current audience composition data”
  • Literature or flyers “directly handed, deposited, [or] fastened on public property or private property without the consent of the owner”
So what’s left if you can’t advertise your business in your local newspaper or radio station, and can’t spring for a billboard? Some might suggest the Almighty Internet. Not so fast. The new rules also prohibits “any website, mobile application, social media or other electronic communication that fails to employ a neutral age-screening mechanism that the user is at least 18 years of age.”

Where Does This Leave Medical Cannabis Businesses?
Maryland’s primary objective in passing these advertising restrictions is likely to protect children and impressionable youths from seeing cannabis, and by extension, shielding them from wanting to actually purchase the products. Out of sight, out of mind, right? But what these restrictions actually do is make it virtually impossible for legal and licensed business owners to spread the word about their goods and services.

Leaning on social media campaigns could be an option…but social media channels have been known to block and remove canna-centric pages and channels.

And it’s not only medical cannabis companies who will take a hit. Patients who rely on the herb may not have as much access to information about all the different products, companies, and services that could help them. For those suffering from chronic and debilitating conditions, access to reliable information and services could be a matter of life and death.

In a country where advertisements for prescription drugs like Zoloft, Viagra, and Movantik (for opioid-induced constipation), are not only legal but acceptable despite the myriad side effects and complications that comes with them (including dependency and death), it seems hypocritical that lawmakers should draw the line at medical cannabis.
 
So, as discussed in the article above that I posted in Nov.....https://vaporasylum.com/threads/maryland-mmj.154/page-9#post-24775.....there is real concern about MD's local ownership requirements and what appears to be back door manuvers to get around that by national companies via the use of "management agreements".

Two days ago, the MMCC issued a bulletin on the subject.....I would say that this bulletin is clear as mud....sigh


upload_2018-12-13_13-31-43.png


upload_2018-12-13_13-32-5.png
 

Sponsored by

VGoodiez 420EDC
Back
Top